228
Views
0
CrossRef citations to date
0
Altmetric
Studies in humans

The protective effects of dietary intake of flavonoids and its subclasses on metabolic syndrome incidence

, , , ORCID Icon & ORCID Icon
Pages 116-126 | Received 28 Jan 2021, Accepted 05 May 2021, Published online: 06 Jun 2021

References

  • Affret A, His M, Severi G, Mancini FR, Arveux P, Clavel‐Chapelon F, Boutron‐Ruault MC, Fagherazzi G. 2018. Influence of a cancer diagnosis on changes in fruit and vegetable consumption according to cancer site, stage at diagnosis and socioeconomic factors: results from the large E3N‐EPIC study. Int J Cancer. 143(7):1678–1687.
  • Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart J-C, James WPT, Loria CM, Smith SC. Jr, 2009. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 120(16):1640–1645.
  • Alfawaz HA, Wani K, Alnaami AM, Al-Saleh Y, Aljohani NJ, Al-Attas OS, Alokail MS, Kumar S, Al-Daghri NM. 2018. Effects of different dietary and lifestyle modification therapies on metabolic syndrome in prediabetic arab patients: A 12-month longitudinal study. Nutrients. 10(3):383.
  • Asghari G, Rezazadeh A, Hosseini-Esfahani F, Mehrabi Y, Mirmiran P, Azizi F. 2012. Reliability, comparative validity and stability of dietary patterns derived from an FFQ in the Tehran Lipid and Glucose Study. Br J Nutr. 108(6):1109–1117.
  • Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, Mehrabi Y, Zahedi-Asl S. 2009. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 10(1):1–15.
  • Azizi F, Hadaegh F, Khalili D, Esteghamati A, Hosseinpanah PF, Delavari A, Mirmiran P, Zabetian A, Mehrabi YE, Kelishadi R. 2010. Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of Obesity. Arch Iran Med. 13 (5):426–428.
  • Baghel SS, Shrivastava N, Baghel RS, Agrawal P, Rajput S. 2012. A review of quercetin: antioxidant and anticancer properties. World J Pharm Sci. 1(1):146–160.
  • Borowiec K, Michalak A. 2021. Flavonoids from edible fruits as therapeutic agents in neuroinflammation–a comprehensive review and update. Crit Food Sci Nutr. 30:1–19.
  • Brodowska KM. 2017. Natural flavonoids: classification, potential role, and application of flavonoid analogues. EJBR. 7(2):108–123.
  • Cano-Ibáñez N, Gea A, Ruiz-Canela M, Corella D, Salas-Salvadó J, Schröder H, Navarrete-Muñoz EM, Romaguera D, Martínez J, A, Barón-López FJ. 2020. Diet quality and nutrient density in subjects with metabolic syndrome: Influence of socioeconomic status and lifestyle factors. A cross-sectional assessment in the PREDIMED-Plus study. Clin Nutr. 39 (4):1161–1173.
  • Cherniack EP. 2011. Polyphenols: planting the seeds of treatment for the metabolic syndrome. Nutrition. 27 (6):617–623.
  • Del Bo C, Bernardi S, Marino M, Porrini M, Tucci M, Guglielmetti S, Cherubini A, Carrieri B, Kirkup B, Kroon P. 2019. Systematic review on polyphenol intake and health outcomes: is there sufficient evidence to define a health-promoting polyphenol-rich dietary pattern? Nutrients. 11 (6):1355.
  • Esfahani FH, Asghari G, Mirmiran P, Azizi F. 2010. Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the Tehran Lipid and Glucose Study. J Epidemiol. 20 (2):150–158.
  • Fernández JM, Rosado-Álvarez D, Da Silva Grigoletto ME, Rangel-Zúñiga OA, Landaeta-Díaz LL, Caballero-Villarraso J, López-Miranda J, Pérez-Jiménez F, Fuentes-Jiménez F. 2012. Moderate-to-high-intensity training and a hypocaloric Mediterranean diet enhance endothelial progenitor cells and fitness in subjects with the metabolic syndrome. Clin Sci. 123 (6):361–373.
  • Galleano M, Calabro V, Prince PD, Litterio MC, Piotrkowski B, Vazquez‐Prieto MA, Miatello RM, Oteiza PI, Fraga CG. 2012. Flavonoids and metabolic syndrome. Ann N Y Acad Sci. 1259 (1):87–94.
  • Godos J, Rapisarda G, Marventano S, Galvano F, Mistretta A, Grosso G. 2017. Association between polyphenol intake and adherence to the Mediterranean diet in Sicily southern Italy. NFS J. 8:1–7.
  • Grosso G, Micek A, Godos J, Pajak A, Sciacca S, Galvano F, Giovannucci EL. 2017. Dietary flavonoid and lignan intake and mortality in prospective cohort studies: Systematic review and dose-response meta-analysis. Am J Epidemiol. 185 (12):1304–1316.
  • Grosso G, Stepaniak U, Micek A, Stefler D, Bobak M, Pająk A. 2017. Dietary polyphenols are inversely associated with metabolic syndrome in Polish adults of the HAPIEE study. Eur J Nutr. 56 (4):1409–1420.
  • Guo X-f, Ruan Y, Li Z-h, Li D. 2019. Flavonoid subclasses and type 2 diabetes mellitus risk: a meta-analysis of prospective cohort studies. Crit Rev Food Sci Nutr. 59 (17):2850–2862.
  • Hejazi J, Ghanavati M, Hejazi E, Poustchi H, Sepanlou SG, Khoshnia M, Gharavi A, Sohrabpour AA, Sotoudeh M, Dawsey SM, et al. 2020. Habitual dietary intake of flavonoids and all-cause and cause-specific mortality: Golestan cohort study. Nutr J. 19 (1):1–25.
  • Hu FB, Stampfer MJ, Rimm E, Ascherio A, Rosner BA, Spiegelman D, Willett WC. 1999. Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol. 149 (6):531–540.
  • Knaze V, Zamora-Ros R, Luján-Barroso L, Romieu I, Scalbert A, Slimani N, Riboli E, Van Rossum CT, Bueno-de-Mesquita HB, Trichopoulou A. 2012. Intake estimation of total and individual flavan-3-ols, proanthocyanidins and theaflavins, their food sources and determinants in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Br J Nutr. 108 (6):1095–1108.
  • Landaeta-Díaz L, Fernández J, Silva-Grigoletto MD, Rosado-Alvarez D, Gómez-Garduño A, Gómez-Delgado F, Lopez-Miranda J, Perez-Jimenez F, Fuentes-Jimenez F. 2013. Mediterranean diet, moderate-to-high intensity training, and health-related quality of life in adults with metabolic syndrome. Eur J Prev Cardiolog. 20 (4):555–564.
  • Malakou E, Linardakis M, Armstrong MEG, Zannidi D, Foster C, Johnson L, Papadaki A. 2018. The combined effect of promoting the Mediterranean diet and physical activity on metabolic risk factors in adults: a systematic review and meta-analysis of randomised controlled trials. Nutrients. 10 (11):1577.
  • Marino M, Del Bo C, Martini D, Porrini M, Riso P. 2020. A review of registered clinical trials on dietary (poly) phenols: past efforts and possible future directions. Foods. 9 (11):1606.
  • Micek A, Godos J, Rio DD, Galvano F, Grosso G. 2021. Dietary flavonoids and cardiovascular disease: a comprehensive dose‐response meta‐analysis. Mol Nutr Food Res. 65 (6):e2001019.
  • Mirmiran P, Bakhshi B, Hosseinpour-Niazi S, Sarbazi N, Hejazi J, Azizi F. 2020. Does the association between patterns of fruit and vegetables and metabolic syndrome incidence vary according to lifestyle factors and socioeconomic status? Nutr Metab Cardiovasc Dis. 30 (8):1322–1336.
  • Mirmiran P, Esfahani FH, Mehrabi Y, Hedayati M, Azizi F. 2010. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr. 13 (05):654–662.
  • Murakami A. 2014. Dose-dependent functionality and toxicity of green tea polyphenols in experimental rodents. Arch Biochem Biophy. 557:3–10.
  • Neri-Numa IA, Cazarin CBB, Ruiz ALTG, Paulino BN, Molina G, Pastore GM. 2020. Targeting flavonoids on modulation of metabolic syndrome. J Funct Foods. 73:104132.
  • O'Neill S, O'Driscoll L. 2015. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 16 (1):1–12.
  • Park HS, Oh SW, Cho S-I, Choi WH, Kim YS. 2004. The metabolic syndrome and associated lifestyle factors among South Korean adults. Int J Epidemiol. 33 (2):328–336.
  • Peterson JJ, Dwyer JT, Jacques PF, McCullough ML. 2012. Associations between flavonoids and cardiovascular disease incidence or mortality in European and US populations. Nutr Rev. 70 (9):491–508.
  • Qin W, Ren B, Wang S, Liang S, He B, Shi X, Wang L, Liang J, Wu F. 2016. Apigenin and naringenin ameliorate PKCβII-associated endothelial dysfunction via regulating ROS/caspase-3 and NO pathway in endothelial cells exposed to high glucose. Vascul Pharmacol. 85:39–49.
  • Qu R, Jia Y, Liu J, Jin S, Han T, Na L. 2018. Dietary flavonoids, copper intake, and risk of metabolic syndrome in Chinese adults. Nutrients. 10 (8):991.
  • Ren B, Qin W, Wu F, Wang S, Pan C, Wang L, Zeng B, Ma S, Liang J. 2016. Apigenin and naringenin regulate glucose and lipid metabolism, and ameliorate vascular dysfunction in type 2 diabetic rats. Eur J Pharmacol. 773:13–23.
  • Romagnolo DF, Selmin OI. 2012. Flavonoids and cancer prevention: a review of the evidence. J Nutr Gerontol Geriatr. 31 (3):206–238.
  • Sandoval V, Sanz-Lamora H, Arias G, Marrero PF, Haro D, Relat J. 2020. Metabolic impact of flavonoids consumption in obesity: from central to peripheral. nutrients. 12 (8):2393.
  • Sharma RK, Sharma N, Kumar U, Samant SS. 2021. Antioxidant properties, phenolics and flavonoids content of some economically important plants from North-west Indian Himalaya. Nat Prod Res. 11:1–5.
  • Sohrab G, Ebrahimof S, Hosseinpour-Niazi S, Yuzbashian E, Mirmiran P, Azizi F. 2018. Association of dietary intakes of total polyphenol and its subclasses with the risk of metabolic syndrome: Tehran lipid and glucose study. Metab Syndr Relat Disord. 16 (6):274–281.
  • Sohrab G, Hosseinpour-Niazi S, Hejazi J, Yuzbashian E, Mirmiran P, Azizi F. 2013. Dietary polyphenols and metabolic syndrome among Iranian adults. Int J Food Sci Nutr. 64 (6):661–667.
  • Vieux F, Maillot M, Rehm CD, Drewnowski A. 2020. Flavonoid intakes in the US diet are linked to higher socioeconomic status and to tea consumption: analyses of NHANES 2011–16 data. J Nutr. 150 (8):2147–2155.
  • Xu H, Luo J, Huang J, Wen Q. 2018. Flavonoids intake and risk of type 2 diabetes mellitus: a meta-analysis of prospective cohort studies. Medicine. 97 (19):e0686.
  • Yamagata K. 2019. Metabolic Syndrome: Preventive Effects of Dietary Flavonoids. Stud Nat Prod Chem. 60:1–28.
  • Yamagata K, Miyashita A, Chino M, Matsufuji H. 2011. Apigenin inhibits tumor necrosis factor alpha plus high glucose-induced LOX-1 expression in human endothelial cells. Microvasc Res. 81 (1):60–67.
  • Yamaoka K, Tango T. 2012. Effects of lifestyle modification on metabolic syndrome: a systematic review and meta-analysis. BMC Med. 10 (1):1–10.
  • Zamora-Ros R, Knaze V, Rothwell JA, Hémon B, Moskal A, Overvad K, Tjønneland A, Kyrø C, Fagherazzi G, Boutron-Ruault M-C, et al. 2016. Dietary polyphenol intake in Europe: the European prospective investigation into cancer and nutrition (EPIC) study. Eur J Nutr. 55 (4):1359–1375.
  • Zhu S, St-Onge M-P, Heshka S, Heymsfield SB. 2004. Lifestyle behaviors associated with lower risk of having the metabolic syndrome. Metabolism. 53(11):1503–1511.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.